Cancer :: Blocking cancer-causing gene improves radiation effectiveness – Jefferson researchers

Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists has found. Using a combination of zebrafish and antisense technology, they’ve shown that the drug flavopiridol works by blocking the activity of a gene, cyclin D1, which is overexpressed in about half of all breast cancers. Similar techniques in the future, the scientists say, may enable researchers to better gauge the effects of drugs.

Breast Cancer :: Younger african-american women are at higher risk

Despite an overall decline in invasive breast cancer in the United States in recent years, African-American women, particularly younger ones, have not seen a significant decline in their rates, according to researchers at the University of Pittsburgh. These findings, which are being presented at the American Public Health Association (AHPA) Annual Meeting in Boston, Nov. 4 ? 8, strongly suggest the need for additional research to understand why these differences persist and to determine whether avoidable or preventable factors account for these puzzling patterns, according to the investigators.

Prostate Cancer :: Mayo Clinic Cancer Center Prostate SPORE Grant Renewed

Mayo Clinic Cancer Center’s Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI) for prostate cancer research has been renewed for an additional five years. SPORE grants are highly competitive awards given to institutions on the cutting edge of translational research in specific types of cancer.

Cancer :: Philips introduces new MR simulator and CT applications

Royal Philips (NYSE: PHG, AEX: PHI) is introducing advances in its portfolio of leading oncology solutions to help physicians define their targets easily and effectively. Recognizing that console time is at a premium in busy imaging centers, Philips is announcing the availability of its Tumor LOC application on the workstation. The company is also unveiling Panorama 1.0T R/T?the first high field open MR simulator. These technologies are on display at the 48th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Philadelphia.

Lung Cancer :: Survival of lung cancer patients increases by up to 92% with annual preventative CAT screenings

The survival of lung cancer patients increases by up to 92% of cases, within ten years of being diagnosed, when annual preventative low-dose radiation CAT screening is carried out. This is the conclusion of the International Early Lung Cancer Action Programme (IELCAP) in which the only Spanish-based centres taking part were the University Hospital and the Centre for Research into Applied Medicine (CIMA), both part of the University of Navarre.

Cancer :: Cancer screening program reduces death rates in NT Indigenous women

The very high incidence of cervical cancer in Northern Territory Indigenous women has fallen by half since the early 1990s, partly as a result of increased participation in Pap Test screening, according to new research published by the Menzies School of Health Research (MSHR) and the NT Department of Health and Community Services (DHCS).

Cancer :: ‘Hair Again’ Gives Cancer Journey Meaning

“Medicine alone is not enough to get you through cancer,” comments Linda Dibblee, breast cancer survivor and winner of the 2006 Lilly Oncology on Canvas International Art Competition and Exhibition. “You have to stay strong and positive through even the darkest times. Having a channel through which you can release your feelings can help you find strength that you never knew you had. For me, painting became my way of expressing all my thoughts, hopes and frustrations, and I truly believe it played a part in helping me beat cancer.”

Breast Cancer :: Doctors able to predict chance of breast cancer returning

Doctors have created a first-ever computer tool to predict the risk of breast cancer returning in the same breast over a 10-year period in women who have had breast conserving surgery to remove only the cancer (lumpectomy), according to a study presented November 6, 2006, at the American Society for Therapeutic Radiology and Oncology’s 48th Annual Meeting in Philadelphia.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack